Takara Holdings Competitors and Similar CompaniesClear all

Takara Holdings's competitors and similar companies include Genentech, UCB, Mankind Pharma and Cipla.

	Takara Holdings Takara Holdings (宝ホールディングス株式会社)is a company that produces and sells beverages, food, printing, and medical supplies in biotechnology, and business fields.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date	Founding Date 1925	Founding Date 1976	Founding Date 1928	Founding Date 1995	Founding Date 1935
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Public
Tags	Tags Food & Beverage Healthcare beverages biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Kyoto, JP HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations New Delhi, IN HQ	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more
Employees	Employees 5,492	Employees 18,077	Employees 9,052	Employees 16,2532% increase	Employees 27,764
Valuation ($)	Valuation ($) 1.5 b	Valuation ($) N/A	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥362.7b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)
Cost of goods	Cost of goods ¥235.3b (FY, 2025)	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)
Gross profit	Gross profit ¥127.4b (FY, 2025)	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit N/A	Gross profit ₹195b (FY, 2026)
Net income	Net income ¥17.3b (FY, 2025)	Net income N/A	Net income €1.6b (FY, 2025)	Net income N/A	Net income ₹38.7b (FY, 2026)